NeuropAWAY

NeuropAWAY is a multi-ingredient nutraceutical formulation developed by VasoCorp, specifically marketed for the management of neuropathic pain and support of nerve health, particularly in individuals with diabetic peripheral neuropathy. The supplement typically contains a proprietary blend of methylcobalamin (Vitamin B12), acetyl-L-carnitine, taurine, L-citrulline, and other B-vitamins. Its mechanism of action involves enhancing blood flow to the nerves through nitric oxide precursors, supporting mitochondrial energy production, and providing essential cofactors for myelin sheath maintenance and nerve regeneration. A 2023 clinical study demonstrated that NeuropAWAY significantly reduced pain intensity and improved nerve conduction velocity in patients with type 2 diabetes compared to placebo.

Brand names

NeuropAWAY

Other names

Nerve Support Formula